Healthcare >> Analyst Interviews >> November 16, 2010

Spending Picks Up In Health Services – Stephen Unger – Lazard Capital Markets

Stephen Unger is a Director and Senior Analyst at Lazard Capital Markets, where he covers the life science tools & diagnostics sector. This sector includes companies within the clinical diagnostics, research equipment & supplies, and drug development services industries. Prior to joining Lazard Capital Markets in October 2009, Mr. Unger was a Managing Director at Bear Stearns, where he covered the pharmaceutical services, life science tools, health care information technology and health care distribution sectors. He was recognized as one of Bear's "Top 5 Analysts" for stock-picking performance for five straight years (2004-2008), an achievement matched by no other analyst in the firm's last 10 years. Mr. Unger was also a Health Care Analyst at Balyasny Asset Management. Prior to his arrival at Bear Stearns in 1998, he spent one year with Piper Jaffray and four years with Deloitte & Touche in Minneapolis. Mr. Unger is a Chartered Financial Analyst, a Certified Public Accountant and a member of the New York Society of Security Analysts and AICPA. He holds a BBA in finance and accounting from the University of Wisconsin, Madison. Profile
TWST: What sectors and companies do you cover in this space?

Mr. Unger: I cover a lot of ground, and it just keeps expanding, which certainly keeps the work interesting. Since 1998 I have been